Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [LIFE] Study).
Messerli
Franz H
FH
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. Fmesserli@aol.com
Mehra
Mandeep R
MR
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017379:Hypertrophy, Left Ventricular / Q000150:complications*; D019808:Losartan / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design
D000959:Antihypertensive Agents; D019808:Losartan